| 4.2 |
12.6 |
GO:0032650 |
regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) interleukin-1 alpha secretion(GO:0050703) |
| 3.5 |
10.4 |
GO:0032915 |
positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 3.1 |
9.2 |
GO:0014877 |
response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 2.7 |
10.9 |
GO:0042938 |
dipeptide transport(GO:0042938) |
| 2.7 |
37.2 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 2.6 |
7.9 |
GO:1901254 |
positive regulation of intracellular transport of viral material(GO:1901254) |
| 2.6 |
7.8 |
GO:0045763 |
negative regulation of cellular amino acid metabolic process(GO:0045763) |
| 2.5 |
10.0 |
GO:0010510 |
regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 2.3 |
7.0 |
GO:0043379 |
memory T cell differentiation(GO:0043379) |
| 2.2 |
6.7 |
GO:0060060 |
post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
| 2.2 |
8.9 |
GO:1900740 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 2.2 |
8.7 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 2.1 |
6.2 |
GO:0035790 |
platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
| 2.0 |
5.9 |
GO:0030827 |
negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
| 1.9 |
9.6 |
GO:0071476 |
cellular hypotonic response(GO:0071476) |
| 1.7 |
5.2 |
GO:1904706 |
negative regulation of vascular smooth muscle cell proliferation(GO:1904706) positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
| 1.7 |
5.2 |
GO:0090327 |
negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
| 1.7 |
5.2 |
GO:1902524 |
negative regulation of interferon-alpha production(GO:0032687) interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) negative regulation of interferon-beta biosynthetic process(GO:0045358) positive regulation of protein K48-linked ubiquitination(GO:1902524) |
| 1.7 |
16.7 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 1.5 |
7.5 |
GO:1900170 |
negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
| 1.5 |
10.2 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 1.4 |
4.2 |
GO:0042998 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 1.4 |
7.0 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
| 1.4 |
1.4 |
GO:1903181 |
regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
| 1.3 |
17.4 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 1.3 |
9.2 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 1.3 |
3.9 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 1.3 |
3.8 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 1.2 |
7.4 |
GO:1903056 |
melanocyte migration(GO:0097324) regulation of lens fiber cell differentiation(GO:1902746) positive regulation of lens fiber cell differentiation(GO:1902748) regulation of melanosome organization(GO:1903056) |
| 1.2 |
8.6 |
GO:0002904 |
positive regulation of B cell apoptotic process(GO:0002904) |
| 1.2 |
19.1 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 1.2 |
10.5 |
GO:0032096 |
negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 1.2 |
3.5 |
GO:2000834 |
androgen secretion(GO:0035935) testosterone secretion(GO:0035936) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
| 1.1 |
4.6 |
GO:0002069 |
columnar/cuboidal epithelial cell maturation(GO:0002069) |
| 1.1 |
4.6 |
GO:0097167 |
circadian regulation of translation(GO:0097167) |
| 1.1 |
11.2 |
GO:0007379 |
segment specification(GO:0007379) |
| 1.1 |
6.6 |
GO:0072318 |
clathrin coat disassembly(GO:0072318) |
| 1.1 |
3.3 |
GO:1903244 |
positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 1.1 |
12.0 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 1.1 |
7.6 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 1.1 |
10.9 |
GO:0090232 |
positive regulation of spindle checkpoint(GO:0090232) |
| 1.1 |
3.3 |
GO:0050925 |
negative regulation of negative chemotaxis(GO:0050925) |
| 1.1 |
8.5 |
GO:0032264 |
IMP salvage(GO:0032264) |
| 1.1 |
2.1 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
| 1.1 |
3.2 |
GO:0046340 |
diacylglycerol catabolic process(GO:0046340) |
| 1.0 |
7.2 |
GO:0034047 |
regulation of protein phosphatase type 2A activity(GO:0034047) |
| 1.0 |
4.0 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 1.0 |
3.9 |
GO:1990743 |
protein sialylation(GO:1990743) |
| 1.0 |
4.8 |
GO:1904721 |
regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) negative regulation of immunoglobulin secretion(GO:0051025) negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
| 0.9 |
10.2 |
GO:1902947 |
regulation of tau-protein kinase activity(GO:1902947) |
| 0.9 |
3.6 |
GO:0051541 |
elastin metabolic process(GO:0051541) |
| 0.9 |
2.7 |
GO:0014826 |
vein smooth muscle contraction(GO:0014826) |
| 0.9 |
2.7 |
GO:0090526 |
regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.9 |
6.9 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
| 0.9 |
1.7 |
GO:2000481 |
positive regulation of cAMP-dependent protein kinase activity(GO:2000481) |
| 0.8 |
10.9 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.8 |
2.5 |
GO:0086069 |
desmosome assembly(GO:0002159) bundle of His cell to Purkinje myocyte communication(GO:0086069) |
| 0.8 |
3.3 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) |
| 0.8 |
3.2 |
GO:0055071 |
cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
| 0.8 |
1.6 |
GO:1902995 |
regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
| 0.8 |
3.1 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.8 |
3.1 |
GO:0042117 |
monocyte activation(GO:0042117) |
| 0.8 |
3.0 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.8 |
3.8 |
GO:1901668 |
regulation of superoxide dismutase activity(GO:1901668) |
| 0.7 |
12.7 |
GO:0099500 |
synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
| 0.7 |
6.0 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.7 |
2.2 |
GO:1900365 |
positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.7 |
14.1 |
GO:0002495 |
antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
| 0.7 |
6.6 |
GO:0036371 |
protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
| 0.7 |
3.6 |
GO:1903726 |
phosphatidylserine biosynthetic process(GO:0006659) negative regulation of phospholipid biosynthetic process(GO:0071072) negative regulation of phospholipid metabolic process(GO:1903726) |
| 0.7 |
2.8 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.7 |
4.2 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 0.7 |
2.1 |
GO:0090403 |
oxidative stress-induced premature senescence(GO:0090403) |
| 0.7 |
1.4 |
GO:0070425 |
negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
| 0.7 |
6.1 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.7 |
2.0 |
GO:1900039 |
positive regulation of cellular response to hypoxia(GO:1900039) |
| 0.7 |
14.9 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.7 |
2.0 |
GO:0017055 |
negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 0.7 |
6.6 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.7 |
2.0 |
GO:0034454 |
microtubule anchoring at centrosome(GO:0034454) |
| 0.7 |
4.6 |
GO:0060762 |
regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.7 |
7.2 |
GO:1901621 |
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.6 |
2.6 |
GO:0019087 |
transformation of host cell by virus(GO:0019087) |
| 0.6 |
9.1 |
GO:1902260 |
negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
| 0.6 |
3.0 |
GO:0060050 |
positive regulation of protein glycosylation(GO:0060050) |
| 0.6 |
4.1 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.6 |
4.1 |
GO:0015840 |
urea transport(GO:0015840) urea transmembrane transport(GO:0071918) |
| 0.6 |
5.8 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.6 |
4.0 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.6 |
3.3 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.6 |
5.0 |
GO:0032693 |
negative regulation of interleukin-10 production(GO:0032693) |
| 0.5 |
9.5 |
GO:0014829 |
vascular smooth muscle contraction(GO:0014829) |
| 0.5 |
8.4 |
GO:0021860 |
pyramidal neuron development(GO:0021860) |
| 0.5 |
1.0 |
GO:0090325 |
regulation of locomotion involved in locomotory behavior(GO:0090325) |
| 0.5 |
2.6 |
GO:0050847 |
progesterone receptor signaling pathway(GO:0050847) |
| 0.5 |
7.2 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.5 |
2.0 |
GO:0008355 |
olfactory learning(GO:0008355) |
| 0.5 |
1.5 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.5 |
1.5 |
GO:1903061 |
regulation of protein lipidation(GO:1903059) positive regulation of protein lipidation(GO:1903061) |
| 0.5 |
4.5 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.5 |
2.0 |
GO:0016081 |
synaptic vesicle docking(GO:0016081) |
| 0.5 |
1.5 |
GO:0060854 |
patterning of lymph vessels(GO:0060854) |
| 0.5 |
4.9 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.5 |
1.5 |
GO:0070305 |
response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
| 0.5 |
1.5 |
GO:0001580 |
detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.5 |
1.0 |
GO:0050912 |
detection of chemical stimulus involved in sensory perception(GO:0050907) detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
| 0.5 |
2.8 |
GO:0071442 |
positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.5 |
2.7 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.5 |
3.2 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.5 |
1.8 |
GO:2001032 |
regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.5 |
4.5 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.5 |
3.2 |
GO:0060842 |
arterial endothelial cell differentiation(GO:0060842) |
| 0.4 |
2.2 |
GO:0019346 |
homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
| 0.4 |
11.9 |
GO:0022401 |
desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
| 0.4 |
17.8 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.4 |
4.4 |
GO:0036120 |
cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.4 |
1.7 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.4 |
5.2 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.4 |
6.8 |
GO:0031280 |
negative regulation of cyclase activity(GO:0031280) |
| 0.4 |
0.4 |
GO:1900037 |
regulation of cellular response to hypoxia(GO:1900037) |
| 0.4 |
1.6 |
GO:1903215 |
negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 0.4 |
0.8 |
GO:0035434 |
copper ion transmembrane transport(GO:0035434) |
| 0.4 |
0.8 |
GO:0044849 |
estrous cycle(GO:0044849) |
| 0.4 |
5.2 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.4 |
3.6 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.4 |
2.0 |
GO:0044314 |
protein K27-linked ubiquitination(GO:0044314) |
| 0.4 |
7.9 |
GO:0006182 |
cGMP biosynthetic process(GO:0006182) |
| 0.4 |
2.0 |
GO:0046684 |
response to pyrethroid(GO:0046684) |
| 0.4 |
3.5 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.4 |
0.8 |
GO:0009812 |
flavonoid metabolic process(GO:0009812) flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
| 0.4 |
2.3 |
GO:0060013 |
righting reflex(GO:0060013) |
| 0.4 |
1.5 |
GO:0015886 |
heme transport(GO:0015886) |
| 0.4 |
0.8 |
GO:1901509 |
regulation of endothelial tube morphogenesis(GO:1901509) |
| 0.4 |
5.3 |
GO:0042182 |
ketone catabolic process(GO:0042182) |
| 0.4 |
6.8 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.4 |
1.9 |
GO:0090292 |
nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.4 |
7.9 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 0.4 |
12.6 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.4 |
14.7 |
GO:0048662 |
negative regulation of smooth muscle cell proliferation(GO:0048662) |
| 0.4 |
1.1 |
GO:0002638 |
negative regulation of immunoglobulin production(GO:0002638) |
| 0.4 |
6.1 |
GO:0002021 |
response to dietary excess(GO:0002021) |
| 0.4 |
1.1 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.4 |
0.7 |
GO:0051026 |
chiasma assembly(GO:0051026) |
| 0.4 |
1.1 |
GO:1903599 |
positive regulation of mitophagy(GO:1903599) |
| 0.4 |
9.9 |
GO:0060074 |
synapse maturation(GO:0060074) |
| 0.4 |
2.5 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
| 0.4 |
3.2 |
GO:2000096 |
positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.3 |
1.4 |
GO:0051771 |
negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 0.3 |
13.2 |
GO:0036465 |
synaptic vesicle recycling(GO:0036465) |
| 0.3 |
5.2 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.3 |
6.2 |
GO:0001553 |
luteinization(GO:0001553) |
| 0.3 |
1.0 |
GO:0036015 |
response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 0.3 |
3.4 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.3 |
1.0 |
GO:0031022 |
nuclear migration along microfilament(GO:0031022) |
| 0.3 |
6.8 |
GO:0001967 |
suckling behavior(GO:0001967) |
| 0.3 |
2.2 |
GO:0014842 |
regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
| 0.3 |
1.6 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.3 |
1.6 |
GO:0021856 |
trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) facioacoustic ganglion development(GO:1903375) positive regulation of male gonad development(GO:2000020) |
| 0.3 |
7.9 |
GO:0007638 |
mechanosensory behavior(GO:0007638) |
| 0.3 |
0.9 |
GO:0060613 |
fat pad development(GO:0060613) |
| 0.3 |
4.2 |
GO:0050901 |
leukocyte tethering or rolling(GO:0050901) |
| 0.3 |
4.5 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.3 |
7.2 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.3 |
2.7 |
GO:0048484 |
enteric nervous system development(GO:0048484) |
| 0.3 |
1.8 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 0.3 |
0.9 |
GO:1904861 |
excitatory synapse assembly(GO:1904861) |
| 0.3 |
0.9 |
GO:1902605 |
heterotrimeric G-protein complex assembly(GO:1902605) |
| 0.3 |
1.4 |
GO:0008655 |
pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
| 0.3 |
1.4 |
GO:0010820 |
positive regulation of T cell chemotaxis(GO:0010820) |
| 0.3 |
9.8 |
GO:1900449 |
regulation of glutamate receptor signaling pathway(GO:1900449) |
| 0.3 |
1.7 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.3 |
4.4 |
GO:0007095 |
mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.3 |
3.3 |
GO:0071378 |
growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
| 0.3 |
1.9 |
GO:0018243 |
protein O-linked glycosylation via threonine(GO:0018243) |
| 0.3 |
0.3 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.3 |
0.5 |
GO:0035633 |
maintenance of blood-brain barrier(GO:0035633) |
| 0.3 |
1.6 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.3 |
2.7 |
GO:0060059 |
embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.3 |
2.4 |
GO:0051195 |
negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.3 |
2.4 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.3 |
1.6 |
GO:0001302 |
replicative cell aging(GO:0001302) |
| 0.3 |
0.5 |
GO:0016080 |
synaptic vesicle targeting(GO:0016080) |
| 0.3 |
3.3 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 0.3 |
1.3 |
GO:0036337 |
Fas signaling pathway(GO:0036337) |
| 0.3 |
3.1 |
GO:0001504 |
neurotransmitter uptake(GO:0001504) |
| 0.2 |
2.0 |
GO:0002903 |
negative regulation of B cell apoptotic process(GO:0002903) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of anion transmembrane transport(GO:1903960) negative regulation of fatty acid transport(GO:2000192) |
| 0.2 |
1.9 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.2 |
1.0 |
GO:0033540 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.2 |
1.2 |
GO:0009052 |
pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.2 |
1.2 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.2 |
0.7 |
GO:0045794 |
negative regulation of cell volume(GO:0045794) |
| 0.2 |
2.6 |
GO:0007097 |
nuclear migration(GO:0007097) |
| 0.2 |
3.1 |
GO:2000114 |
regulation of establishment of cell polarity(GO:2000114) |
| 0.2 |
3.3 |
GO:0055059 |
asymmetric neuroblast division(GO:0055059) |
| 0.2 |
2.1 |
GO:0042759 |
long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.2 |
1.4 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.2 |
1.1 |
GO:0032911 |
nerve growth factor production(GO:0032902) negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.2 |
15.8 |
GO:0050885 |
neuromuscular process controlling balance(GO:0050885) |
| 0.2 |
3.7 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 0.2 |
1.1 |
GO:1902993 |
positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
| 0.2 |
3.4 |
GO:0019369 |
arachidonic acid metabolic process(GO:0019369) |
| 0.2 |
0.6 |
GO:2000598 |
regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
| 0.2 |
0.9 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.2 |
4.4 |
GO:0045581 |
negative regulation of T cell differentiation(GO:0045581) |
| 0.2 |
4.4 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.2 |
2.9 |
GO:0007035 |
vacuolar acidification(GO:0007035) |
| 0.2 |
0.4 |
GO:0032423 |
regulation of mismatch repair(GO:0032423) |
| 0.2 |
1.7 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
| 0.2 |
1.7 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) |
| 0.2 |
0.8 |
GO:2000301 |
negative regulation of synaptic vesicle transport(GO:1902804) negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.2 |
1.2 |
GO:0046602 |
regulation of mitotic centrosome separation(GO:0046602) |
| 0.2 |
1.6 |
GO:0035635 |
entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
| 0.2 |
0.8 |
GO:0036451 |
cap mRNA methylation(GO:0036451) |
| 0.2 |
0.6 |
GO:1904683 |
regulation of metalloendopeptidase activity(GO:1904683) negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
| 0.2 |
1.0 |
GO:0032485 |
regulation of Ral protein signal transduction(GO:0032485) |
| 0.2 |
2.2 |
GO:1901741 |
positive regulation of myoblast fusion(GO:1901741) |
| 0.2 |
1.2 |
GO:0002931 |
response to ischemia(GO:0002931) |
| 0.2 |
0.8 |
GO:0010453 |
regulation of cell fate commitment(GO:0010453) |
| 0.2 |
3.7 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.2 |
3.9 |
GO:0097320 |
membrane tubulation(GO:0097320) |
| 0.2 |
1.5 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.2 |
0.6 |
GO:0006553 |
lysine metabolic process(GO:0006553) |
| 0.2 |
0.7 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.2 |
0.6 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.2 |
1.8 |
GO:0051150 |
regulation of smooth muscle cell differentiation(GO:0051150) |
| 0.2 |
0.9 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.2 |
0.5 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.2 |
1.1 |
GO:0002317 |
plasma cell differentiation(GO:0002317) |
| 0.2 |
1.6 |
GO:0006532 |
aspartate biosynthetic process(GO:0006532) |
| 0.2 |
0.7 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.2 |
2.1 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.2 |
3.7 |
GO:0010107 |
potassium ion import(GO:0010107) |
| 0.2 |
0.7 |
GO:0045925 |
positive regulation of female receptivity(GO:0045925) |
| 0.2 |
5.1 |
GO:0050919 |
negative chemotaxis(GO:0050919) |
| 0.2 |
1.0 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.2 |
1.3 |
GO:0003215 |
cardiac right ventricle morphogenesis(GO:0003215) |
| 0.2 |
0.8 |
GO:0006625 |
protein targeting to peroxisome(GO:0006625) protein import into peroxisome matrix(GO:0016558) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.2 |
2.8 |
GO:0006744 |
ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.2 |
0.6 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.2 |
1.1 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.2 |
1.0 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.2 |
3.5 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.2 |
1.7 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.2 |
2.0 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.2 |
1.2 |
GO:0045986 |
negative regulation of smooth muscle contraction(GO:0045986) |
| 0.2 |
2.0 |
GO:0001780 |
neutrophil homeostasis(GO:0001780) negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.2 |
0.5 |
GO:0071455 |
cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) cellular response to nitric oxide(GO:0071732) |
| 0.2 |
0.9 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.2 |
1.2 |
GO:0032088 |
negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
| 0.1 |
0.9 |
GO:0046103 |
ADP biosynthetic process(GO:0006172) inosine biosynthetic process(GO:0046103) |
| 0.1 |
0.4 |
GO:0035582 |
sequestering of BMP in extracellular matrix(GO:0035582) |
| 0.1 |
1.5 |
GO:0000042 |
protein targeting to Golgi(GO:0000042) |
| 0.1 |
0.7 |
GO:0071985 |
multivesicular body sorting pathway(GO:0071985) |
| 0.1 |
2.9 |
GO:0006054 |
N-acetylneuraminate metabolic process(GO:0006054) |
| 0.1 |
0.5 |
GO:0007128 |
meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
| 0.1 |
1.9 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.1 |
8.2 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.1 |
4.2 |
GO:0010765 |
positive regulation of sodium ion transport(GO:0010765) |
| 0.1 |
3.5 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.1 |
1.7 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.1 |
1.0 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.1 |
1.3 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.1 |
1.3 |
GO:0071880 |
adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
| 0.1 |
0.8 |
GO:0006527 |
arginine catabolic process(GO:0006527) |
| 0.1 |
0.5 |
GO:0090091 |
positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.1 |
1.5 |
GO:0008209 |
androgen metabolic process(GO:0008209) |
| 0.1 |
1.9 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.1 |
1.7 |
GO:0097094 |
craniofacial suture morphogenesis(GO:0097094) |
| 0.1 |
3.9 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.1 |
2.6 |
GO:0007212 |
dopamine receptor signaling pathway(GO:0007212) |
| 0.1 |
2.1 |
GO:0000289 |
nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.1 |
1.4 |
GO:0032784 |
regulation of DNA-templated transcription, elongation(GO:0032784) |
| 0.1 |
9.3 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 0.1 |
1.0 |
GO:0034551 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.1 |
2.2 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.1 |
0.7 |
GO:0006198 |
cAMP catabolic process(GO:0006198) |
| 0.1 |
8.1 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.1 |
0.7 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.1 |
2.6 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.1 |
2.0 |
GO:0036342 |
post-anal tail morphogenesis(GO:0036342) |
| 0.1 |
1.2 |
GO:0051103 |
DNA ligation involved in DNA repair(GO:0051103) |
| 0.1 |
0.7 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.1 |
2.2 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.1 |
0.5 |
GO:0046501 |
protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.1 |
0.7 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.1 |
3.1 |
GO:0006805 |
xenobiotic metabolic process(GO:0006805) |
| 0.1 |
0.4 |
GO:2000258 |
negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
| 0.1 |
1.9 |
GO:0035774 |
positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
| 0.1 |
0.7 |
GO:0097039 |
protein linear polyubiquitination(GO:0097039) |
| 0.1 |
0.2 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.1 |
0.9 |
GO:0015868 |
purine ribonucleotide transport(GO:0015868) |
| 0.1 |
1.0 |
GO:1990440 |
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.1 |
1.5 |
GO:0048714 |
positive regulation of oligodendrocyte differentiation(GO:0048714) |
| 0.1 |
0.2 |
GO:0046950 |
cellular ketone body metabolic process(GO:0046950) |
| 0.1 |
0.5 |
GO:0006361 |
transcription initiation from RNA polymerase I promoter(GO:0006361) |
| 0.1 |
0.2 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.1 |
1.2 |
GO:2000505 |
regulation of energy homeostasis(GO:2000505) |
| 0.1 |
3.1 |
GO:0034605 |
cellular response to heat(GO:0034605) |
| 0.1 |
0.4 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.1 |
0.3 |
GO:0010612 |
regulation of cardiac muscle adaptation(GO:0010612) |
| 0.1 |
5.4 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
| 0.1 |
0.6 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.1 |
1.4 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
| 0.1 |
1.4 |
GO:0046627 |
negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
| 0.1 |
2.8 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.1 |
0.8 |
GO:1900112 |
regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.1 |
2.1 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.1 |
0.2 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 0.1 |
4.2 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.1 |
0.7 |
GO:0034244 |
negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.1 |
2.4 |
GO:0050868 |
negative regulation of T cell activation(GO:0050868) |
| 0.1 |
4.4 |
GO:0046323 |
glucose import(GO:0046323) |
| 0.1 |
0.1 |
GO:0097105 |
presynaptic membrane assembly(GO:0097105) |
| 0.1 |
1.2 |
GO:0016101 |
diterpenoid metabolic process(GO:0016101) |
| 0.1 |
0.6 |
GO:0044804 |
nucleophagy(GO:0044804) |
| 0.1 |
0.2 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.1 |
0.2 |
GO:0007602 |
phototransduction(GO:0007602) |
| 0.1 |
1.4 |
GO:0070536 |
protein K63-linked deubiquitination(GO:0070536) |
| 0.1 |
1.4 |
GO:0045724 |
positive regulation of cilium assembly(GO:0045724) |
| 0.1 |
1.9 |
GO:0042058 |
regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
| 0.1 |
0.7 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.1 |
1.3 |
GO:0015991 |
energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.1 |
1.3 |
GO:0099643 |
neurotransmitter secretion(GO:0007269) presynaptic process involved in chemical synaptic transmission(GO:0099531) signal release from synapse(GO:0099643) |
| 0.1 |
1.1 |
GO:0097178 |
ruffle assembly(GO:0097178) |
| 0.1 |
1.0 |
GO:0048025 |
negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.1 |
0.6 |
GO:0051788 |
response to misfolded protein(GO:0051788) cellular response to misfolded protein(GO:0071218) |
| 0.1 |
0.1 |
GO:0051987 |
positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
| 0.1 |
0.9 |
GO:0070542 |
response to fatty acid(GO:0070542) |
| 0.1 |
0.5 |
GO:0044406 |
adhesion of symbiont to host(GO:0044406) |
| 0.1 |
1.3 |
GO:1904893 |
negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.1 |
1.9 |
GO:0000381 |
regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.1 |
1.4 |
GO:0006760 |
folic acid-containing compound metabolic process(GO:0006760) |
| 0.1 |
0.4 |
GO:0042558 |
pteridine-containing compound metabolic process(GO:0042558) |
| 0.1 |
0.2 |
GO:0061002 |
negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.1 |
0.9 |
GO:0007340 |
acrosome reaction(GO:0007340) |
| 0.1 |
1.0 |
GO:0050873 |
brown fat cell differentiation(GO:0050873) |
| 0.1 |
0.2 |
GO:0071360 |
cellular response to exogenous dsRNA(GO:0071360) |
| 0.1 |
0.4 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.1 |
0.4 |
GO:0000414 |
regulation of histone H3-K36 methylation(GO:0000414) |
| 0.1 |
0.2 |
GO:0032930 |
positive regulation of superoxide anion generation(GO:0032930) |
| 0.1 |
1.0 |
GO:0030851 |
granulocyte differentiation(GO:0030851) |
| 0.1 |
0.5 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.1 |
0.2 |
GO:0070269 |
pyroptosis(GO:0070269) |
| 0.1 |
0.5 |
GO:0036230 |
granulocyte activation(GO:0036230) |
| 0.1 |
7.6 |
GO:0043547 |
positive regulation of GTPase activity(GO:0043547) |
| 0.0 |
0.8 |
GO:0097352 |
autophagosome maturation(GO:0097352) |
| 0.0 |
0.3 |
GO:0097460 |
positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) ferrous iron import into cell(GO:0097460) |
| 0.0 |
0.2 |
GO:0048318 |
axial mesoderm development(GO:0048318) |
| 0.0 |
1.7 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
| 0.0 |
1.1 |
GO:0045494 |
photoreceptor cell maintenance(GO:0045494) |
| 0.0 |
2.4 |
GO:0050806 |
positive regulation of synaptic transmission(GO:0050806) |
| 0.0 |
1.1 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.0 |
1.5 |
GO:0051290 |
protein heterotetramerization(GO:0051290) |
| 0.0 |
2.3 |
GO:0042147 |
retrograde transport, endosome to Golgi(GO:0042147) |
| 0.0 |
0.4 |
GO:0019884 |
antigen processing and presentation of exogenous antigen(GO:0019884) |
| 0.0 |
0.2 |
GO:1900864 |
mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.0 |
0.8 |
GO:0060612 |
adipose tissue development(GO:0060612) |
| 0.0 |
0.5 |
GO:0061014 |
positive regulation of mRNA catabolic process(GO:0061014) |
| 0.0 |
0.3 |
GO:0035988 |
chondrocyte proliferation(GO:0035988) |
| 0.0 |
1.9 |
GO:0048477 |
oogenesis(GO:0048477) |
| 0.0 |
0.2 |
GO:0071941 |
nitrogen cycle metabolic process(GO:0071941) |
| 0.0 |
0.4 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.0 |
0.2 |
GO:0035092 |
sperm chromatin condensation(GO:0035092) |
| 0.0 |
0.5 |
GO:0045475 |
locomotor rhythm(GO:0045475) |
| 0.0 |
1.4 |
GO:0072384 |
organelle transport along microtubule(GO:0072384) |
| 0.0 |
0.6 |
GO:0006767 |
water-soluble vitamin metabolic process(GO:0006767) |
| 0.0 |
0.5 |
GO:0080111 |
DNA demethylation(GO:0080111) |
| 0.0 |
0.5 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.0 |
0.8 |
GO:0045824 |
negative regulation of innate immune response(GO:0045824) |
| 0.0 |
0.2 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.0 |
1.3 |
GO:0043488 |
regulation of mRNA stability(GO:0043488) |
| 0.0 |
0.1 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.0 |
0.3 |
GO:0021527 |
spinal cord association neuron differentiation(GO:0021527) |
| 0.0 |
0.2 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.0 |
0.2 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.0 |
0.1 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.0 |
0.9 |
GO:0006687 |
glycosphingolipid metabolic process(GO:0006687) |
| 0.0 |
0.2 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.0 |
1.8 |
GO:0006334 |
nucleosome assembly(GO:0006334) |
| 0.0 |
0.2 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
| 0.0 |
0.2 |
GO:0061099 |
negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.0 |
0.7 |
GO:0000266 |
mitochondrial fission(GO:0000266) |
| 0.0 |
0.6 |
GO:0000045 |
autophagosome assembly(GO:0000045) |
| 0.0 |
0.2 |
GO:0009081 |
branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
| 0.0 |
0.1 |
GO:0045579 |
positive regulation of B cell differentiation(GO:0045579) |
| 0.0 |
0.1 |
GO:0051775 |
response to redox state(GO:0051775) |
| 0.0 |
0.1 |
GO:1904153 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.0 |
1.9 |
GO:0006813 |
potassium ion transport(GO:0006813) |
| 0.0 |
0.3 |
GO:0043001 |
Golgi to plasma membrane protein transport(GO:0043001) |
| 0.0 |
0.3 |
GO:0002474 |
antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
| 0.0 |
0.0 |
GO:1903038 |
negative regulation of leukocyte cell-cell adhesion(GO:1903038) |
| 0.0 |
1.5 |
GO:0046488 |
phosphatidylinositol metabolic process(GO:0046488) |
| 0.0 |
1.2 |
GO:0007605 |
sensory perception of sound(GO:0007605) |
| 0.0 |
0.4 |
GO:0030488 |
tRNA methylation(GO:0030488) |
| 0.0 |
0.0 |
GO:1904738 |
vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
| 0.0 |
0.0 |
GO:0017121 |
phospholipid scrambling(GO:0017121) |
| 0.0 |
0.3 |
GO:0001947 |
heart looping(GO:0001947) |
| 0.0 |
0.4 |
GO:0061077 |
chaperone-mediated protein folding(GO:0061077) |
| 0.0 |
0.1 |
GO:0030811 |
regulation of glycolytic process(GO:0006110) regulation of nucleotide catabolic process(GO:0030811) |